Key result
Having an outpatient breast biopsy was significantly associated with an increased likelihood of a surgery waiting time of fewer than 42 days (OR 3.89) compared to inpatient biopsy.
Cohort (n=604)
Yes
Evaluation of preoperative clinical pathways for breast cancer patients highlights the need for standardized coordination to meet EUSOMA quality indicators, particularly regarding multidisciplinary discussions and waiting times.
Compliance with select EUSOMA preoperative indicators varied by center type; leaves open whether standardized pathways improve adherence in routine breast cancer care.
BACKGROUND: The European Society of Breast Cancer Specialists (EUSOMA) has defined quality indicators for breast cancer (BC). The aim of this study was to describe the preoperative clinical pathway of breast cancer patients and evaluate the determinants of compliance with EUSOMA quality indicators in the Optisoins01 cohort. METHODS: Optisoins01 is a prospective, multicentric study. Data from operable BC patients were collected, including results from before surgery to 1 year follow-up. Seven preoperative EUSOMA quality indicators were compared with the clinical pathways Optisoins01. RESULTS: Six hundred and four patients were included. European Society of Breast Cancer Specialists targets were reached for indicator 1 (completeness of clinical and imaging diagnostic work-up), 3 (preoperative definitive diagnosis) and 5 (waiting time). For indicator 8 (multidisciplinary discussion), the minimum standard of 90% of the patients was reached only in general hospitals and comprehensive cancer centres. Having more than 1 medical examination within the centre was associated with an increased waiting time for surgery, whereas it was reduced by having an outpatient breast biopsy. The comprehensive cancer centre type was the only parameter associated with the other quality indicators. CONCLUSIONS: European Society of Breast Cancer Specialists quality indicators are a useful tool to evaluate care organisations. This study highlights the need for a standardised and coordinated preoperative clinical pathway.
No takes yet. Share an insight, caveat, or question.
Héquet et al. (2017) conducted a cohort in Operable breast cancer (n=604). Outpatient breast biopsy vs. Inpatient breast biopsy was evaluated on Waiting time for surgery of fewer than 42 days (OR 3.89, 95% CI 2.06-7.60, p=<0.005). Having an outpatient breast biopsy was significantly associated with an increased likelihood of a surgery waiting time of fewer than 42 days (OR 3.89) compared to inpatient biopsy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: